Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ecovyst (ECVT) Payables (2016 - 2025)

Ecovyst (ECVT) has disclosed Payables for 10 consecutive years, with $48.0 million as the latest value for Q4 2025.

  • Quarterly Payables rose 45.88% to $48.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $48.0 million through Dec 2025, up 45.88% year-over-year, with the annual reading at $48.0 million for FY2025, 45.88% up from the prior year.
  • Payables hit $48.0 million in Q4 2025 for Ecovyst, up from $47.1 million in the prior quarter.
  • In the past five years, Payables ranged from a high of $57.9 million in Q2 2022 to a low of $32.3 million in Q3 2023.
  • Historically, Payables has averaged $42.1 million across 5 years, with a median of $41.1 million in 2021.
  • Biggest five-year swings in Payables: crashed 67.0% in 2021 and later soared 45.88% in 2025.
  • Year by year, Payables stood at $51.9 million in 2021, then fell by 22.83% to $40.0 million in 2022, then rose by 0.44% to $40.2 million in 2023, then dropped by 18.06% to $32.9 million in 2024, then skyrocketed by 45.88% to $48.0 million in 2025.
  • Business Quant data shows Payables for ECVT at $48.0 million in Q4 2025, $47.1 million in Q3 2025, and $47.9 million in Q2 2025.